TARGET-NEURO

About this trial

Last updated 2 years ago

Study ID

TARGET-NEURO

Status

Not yet recruiting

Type

Observational

Placebo

Accepting

18+ Years

All

Not accepting

Healthy Volunteers

Trial Timing

Started 2 years ago

TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).

Disease Cohort

Inclusion Criteria:

•Adult patients at the time of enrollment with a diagnosis of ADRD, MCI, PD, or MS by
select ICD-10 codes in the EHR interface

Exclusion Criteria:

- Death

- Manual removal (sponsor or site request)

- No EHR interface encounter > 3 years

Engaged Cohort

Inclusion Criteria:

- Adult patients diagnosed and managed for these conditions invited to participate

- Ability to provide written informed consent (or have a legally authorized
representative to provide informed consent)

- Care partners may be invited to participate in surveys and will provide informed
consent.

Exclusion Criteria:

- Patient expressed desire to withdraw consent to complete PROs

- Care partner expressed desire to withdraw consent to complete PROs

- Failure to complete PROs within 24 weeks of initial invitation

- Greater than 24 months lapse of survey completion after baseline surveys completed

- Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort

Age Cohort

Inclusion Criteria:

•Adult patients aged 60 and older at time of enrollment

Exclusion Criteria:

- Death

- Manual removal (sponsor or site request)

- No EHR interface encounter > 3 years

An Observational Study of Patients Living With Chronic Neurological Diseases